Abstract

BackgroundLow-grade myofibroblastic sarcoma (LGMS) is a poorly studied, rare, soft tissue sarcoma. LGMS is characterized by a low malignancy potential, tendency for local recurrence, and low likelihood of distant metastases. However, no studies have reported on the surgical treatment method and its long-term outcomes.MethodsWe included all patients treated for LGMS at our institution between March 2010 and March 2021. Medical charts were retrospectively reviewed to collect demographic information, as well as information about the clinical course, tumor characteristics, and outcomes. Statistical analysis was performed to identify the factors associated with the recurrence rate.ResultsFifteen patients who underwent surgical treatment were enrolled in this study. There were seven cases in the upper extremities, four in the trunk area, three in the lower extremities, and one in the head and neck area. There were no metastatic cases and two cases of local recurrence.ConclusionsThe incidence of LGMS in the extremities or trunk may be higher than expected based on the current literature. Univariate analysis showed that local tissue invasion and surgical method could be associated with local recurrence. Although further large studies are needed to establish risk factors of local recurrence or extent of resection margins, based on our study, wide local excision under the proper diagnosis is the most important treatment.

Highlights

  • Low-grade myofibroblastic sarcoma (LGMS) is an extremely rare type of malignant tumor that was first reported by Mentzel et al [1] These tumors originate from the mesenchyme and show myofibroblastic proliferation with fibromatosis-like features [2]

  • We investigated all patients surgically treated for LGMS at our institution between March 2010 and March 2021

  • The recurrent lesion was resected with clear margins, and no further recurrence was observed 22 months postoperatively

Read more

Summary

Introduction

Low-grade myofibroblastic sarcoma (LGMS) is an extremely rare type of malignant tumor that was first reported by Mentzel et al [1] These tumors originate from the mesenchyme and show myofibroblastic proliferation with fibromatosis-like features [2]. LGMS was first classified as a new group of soft tissue and bone tumors by the World Health Organization in 2002, and this classification was maintained in 2013 [3]. Kim et al World Journal of Surgical Oncology (2021) 19:339. Low-grade myofibroblastic sarcoma (LGMS) is a poorly studied, rare, soft tissue sarcoma. LGMS is characterized by a low malignancy potential, tendency for local recurrence, and low likelihood of distant metastases. No studies have reported on the surgical treatment method and its long-term outcomes

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call